img

Global Hemoglobinopathy Testing Services Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hemoglobinopathy Testing Services Market Insights, Forecast to 2034

Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Hemoglobin is present in the red blood cells that transports oxygen from the lung to the body.
Market Analysis and InsightsGlobal Hemoglobinopathy Testing Services Market
Global Hemoglobinopathy Testing Services market is expected to reach to US$ 911 million in 2024, with a positive growth of %, compared with US$ 825 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Hemoglobinopathy Testing Services industry is evaluated to reach US$ 1558.4 million in 2029. The CAGR will be 9.4% during 2024 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Hemoglobinopathy Testing Services market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Hemoglobinopathy Testing Services market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Novartis
AstraZeneca
Bluebird Bio
Bristol-Myers Squibb
Emmaus Medical
Acceleron Pharma
HemaQuest Pharmaceuticals
Eli Lilly and Company
Celgene Corporation
Segment by Type
Hydroxyurea
Glutamine
Zynteglo
Luspatercept
Others

Segment by Application


Sickle Cell Diseases
Thalassemia
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Hemoglobinopathy Testing Services introduction, etc. Hemoglobinopathy Testing Services Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Hemoglobinopathy Testing Services
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Hydroxyurea
1.2.3 Glutamine
1.2.4 Zynteglo
1.2.5 Luspatercept
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hemoglobinopathy Testing Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Sickle Cell Diseases
1.3.3 Thalassemia
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemoglobinopathy Testing Services Market Perspective (2018-2029)
2.2 Global Hemoglobinopathy Testing Services Growth Trends by Region
2.2.1 Hemoglobinopathy Testing Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hemoglobinopathy Testing Services Historic Market Size by Region (2018-2024)
2.2.3 Hemoglobinopathy Testing Services Forecasted Market Size by Region (2024-2029)
2.3 Hemoglobinopathy Testing Services Market Dynamics
2.3.1 Hemoglobinopathy Testing Services Industry Trends
2.3.2 Hemoglobinopathy Testing Services Market Drivers
2.3.3 Hemoglobinopathy Testing Services Market Challenges
2.3.4 Hemoglobinopathy Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hemoglobinopathy Testing Services by Players
3.1.1 Global Hemoglobinopathy Testing Services Revenue by Players (2018-2024)
3.1.2 Global Hemoglobinopathy Testing Services Revenue Market Share by Players (2018-2024)
3.2 Global Hemoglobinopathy Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hemoglobinopathy Testing Services, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Hemoglobinopathy Testing Services Market Concentration Ratio
3.4.1 Global Hemoglobinopathy Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Testing Services Revenue in 2022
3.5 Global Key Players of Hemoglobinopathy Testing Services Head office and Area Served
3.6 Global Key Players of Hemoglobinopathy Testing Services, Product and Application
3.7 Global Key Players of Hemoglobinopathy Testing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemoglobinopathy Testing Services Breakdown Data by Type
4.1 Global Hemoglobinopathy Testing Services Historic Market Size by Type (2018-2024)
4.2 Global Hemoglobinopathy Testing Services Forecasted Market Size by Type (2024-2029)
5 Hemoglobinopathy Testing Services Breakdown Data by Application
5.1 Global Hemoglobinopathy Testing Services Historic Market Size by Application (2018-2024)
5.2 Global Hemoglobinopathy Testing Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hemoglobinopathy Testing Services Market Size (2018-2029)
6.2 North America Hemoglobinopathy Testing Services Market Size by Type
6.2.1 North America Hemoglobinopathy Testing Services Market Size by Type (2018-2024)
6.2.2 North America Hemoglobinopathy Testing Services Market Size by Type (2024-2029)
6.2.3 North America Hemoglobinopathy Testing Services Market Share by Type (2018-2029)
6.3 North America Hemoglobinopathy Testing Services Market Size by Application
6.3.1 North America Hemoglobinopathy Testing Services Market Size by Application (2018-2024)
6.3.2 North America Hemoglobinopathy Testing Services Market Size by Application (2024-2029)
6.3.3 North America Hemoglobinopathy Testing Services Market Share by Application (2018-2029)
6.4 North America Hemoglobinopathy Testing Services Market Size by Country
6.4.1 North America Hemoglobinopathy Testing Services Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Hemoglobinopathy Testing Services Market Size by Country (2018-2024)
6.4.3 North America Hemoglobinopathy Testing Services Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hemoglobinopathy Testing Services Market Size (2018-2029)
7.2 Europe Hemoglobinopathy Testing Services Market Size by Type
7.2.1 Europe Hemoglobinopathy Testing Services Market Size by Type (2018-2024)
7.2.2 Europe Hemoglobinopathy Testing Services Market Size by Type (2024-2029)
7.2.3 Europe Hemoglobinopathy Testing Services Market Share by Type (2018-2029)
7.3 Europe Hemoglobinopathy Testing Services Market Size by Application
7.3.1 Europe Hemoglobinopathy Testing Services Market Size by Application (2018-2024)
7.3.2 Europe Hemoglobinopathy Testing Services Market Size by Application (2024-2029)
7.3.3 Europe Hemoglobinopathy Testing Services Market Share by Application (2018-2029)
7.4 Europe Hemoglobinopathy Testing Services Market Size by Country
7.4.1 Europe Hemoglobinopathy Testing Services Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Hemoglobinopathy Testing Services Market Size by Country (2018-2024)
7.4.3 Europe Hemoglobinopathy Testing Services Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hemoglobinopathy Testing Services Market Size (2018-2029)
8.2 China Hemoglobinopathy Testing Services Market Size by Type
8.2.1 China Hemoglobinopathy Testing Services Market Size by Type (2018-2024)
8.2.2 China Hemoglobinopathy Testing Services Market Size by Type (2024-2029)
8.2.3 China Hemoglobinopathy Testing Services Market Share by Type (2018-2029)
8.3 China Hemoglobinopathy Testing Services Market Size by Application
8.3.1 China Hemoglobinopathy Testing Services Market Size by Application (2018-2024)
8.3.2 China Hemoglobinopathy Testing Services Market Size by Application (2024-2029)
8.3.3 China Hemoglobinopathy Testing Services Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Hemoglobinopathy Testing Services Market Size (2018-2029)
9.2 Asia Hemoglobinopathy Testing Services Market Size by Type
9.2.1 Asia Hemoglobinopathy Testing Services Market Size by Type (2018-2024)
9.2.2 Asia Hemoglobinopathy Testing Services Market Size by Type (2024-2029)
9.2.3 Asia Hemoglobinopathy Testing Services Market Share by Type (2018-2029)
9.3 Asia Hemoglobinopathy Testing Services Market Size by Application
9.3.1 Asia Hemoglobinopathy Testing Services Market Size by Application (2018-2024)
9.3.2 Asia Hemoglobinopathy Testing Services Market Size by Application (2024-2029)
9.3.3 Asia Hemoglobinopathy Testing Services Market Share by Application (2018-2029)
9.4 Asia Hemoglobinopathy Testing Services Market Size by Region
9.4.1 Asia Hemoglobinopathy Testing Services Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Hemoglobinopathy Testing Services Market Size by Region (2018-2024)
9.4.3 Asia Hemoglobinopathy Testing Services Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Hemoglobinopathy Testing Services Introduction
11.1.4 Novartis Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.1.5 Novartis Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Hemoglobinopathy Testing Services Introduction
11.2.4 AstraZeneca Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.2.5 AstraZeneca Recent Developments
11.3 Bluebird Bio
11.3.1 Bluebird Bio Company Details
11.3.2 Bluebird Bio Business Overview
11.3.3 Bluebird Bio Hemoglobinopathy Testing Services Introduction
11.3.4 Bluebird Bio Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.3.5 Bluebird Bio Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Hemoglobinopathy Testing Services Introduction
11.4.4 Bristol-Myers Squibb Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Emmaus Medical
11.5.1 Emmaus Medical Company Details
11.5.2 Emmaus Medical Business Overview
11.5.3 Emmaus Medical Hemoglobinopathy Testing Services Introduction
11.5.4 Emmaus Medical Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.5.5 Emmaus Medical Recent Developments
11.6 Acceleron Pharma
11.6.1 Acceleron Pharma Company Details
11.6.2 Acceleron Pharma Business Overview
11.6.3 Acceleron Pharma Hemoglobinopathy Testing Services Introduction
11.6.4 Acceleron Pharma Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.6.5 Acceleron Pharma Recent Developments
11.7 HemaQuest Pharmaceuticals
11.7.1 HemaQuest Pharmaceuticals Company Details
11.7.2 HemaQuest Pharmaceuticals Business Overview
11.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Introduction
11.7.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.7.5 HemaQuest Pharmaceuticals Recent Developments
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Hemoglobinopathy Testing Services Introduction
11.8.4 Eli Lilly and Company Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.8.5 Eli Lilly and Company Recent Developments
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Details
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Hemoglobinopathy Testing Services Introduction
11.9.4 Celgene Corporation Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.9.5 Celgene Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Hydroxyurea
Table 3. Key Players of Glutamine
Table 4. Key Players of Zynteglo
Table 5. Key Players of Luspatercept
Table 6. Key Players of Others
Table 7. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Hemoglobinopathy Testing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Hemoglobinopathy Testing Services Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Hemoglobinopathy Testing Services Market Share by Region (2018-2024)
Table 11. Global Hemoglobinopathy Testing Services Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Hemoglobinopathy Testing Services Market Share by Region (2024-2029)
Table 13. Hemoglobinopathy Testing Services Market Trends
Table 14. Hemoglobinopathy Testing Services Market Drivers
Table 15. Hemoglobinopathy Testing Services Market Challenges
Table 16. Hemoglobinopathy Testing Services Market Restraints
Table 17. Global Hemoglobinopathy Testing Services Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Hemoglobinopathy Testing Services Revenue Share by Players (2018-2024)
Table 19. Global Top Hemoglobinopathy Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Testing Services as of 2022)
Table 20. Global Hemoglobinopathy Testing Services Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by Hemoglobinopathy Testing Services Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of Hemoglobinopathy Testing Services, Headquarters and Area Served
Table 23. Global Key Players of Hemoglobinopathy Testing Services, Product and Application
Table 24. Global Key Players of Hemoglobinopathy Testing Services, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hemoglobinopathy Testing Services Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2018-2024)
Table 28. Global Hemoglobinopathy Testing Services Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2024-2029)
Table 30. Global Hemoglobinopathy Testing Services Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Hemoglobinopathy Testing Services Revenue Share by Application (2018-2024)
Table 32. Global Hemoglobinopathy Testing Services Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Hemoglobinopathy Testing Services Revenue Share by Application (2024-2029)
Table 34. North America Hemoglobinopathy Testing Services Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America Hemoglobinopathy Testing Services Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Hemoglobinopathy Testing Services Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America Hemoglobinopathy Testing Services Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Hemoglobinopathy Testing Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Hemoglobinopathy Testing Services Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America Hemoglobinopathy Testing Services Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Hemoglobinopathy Testing Services Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe Hemoglobinopathy Testing Services Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Hemoglobinopathy Testing Services Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe Hemoglobinopathy Testing Services Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Hemoglobinopathy Testing Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Hemoglobinopathy Testing Services Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe Hemoglobinopathy Testing Services Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Hemoglobinopathy Testing Services Market Size by Type (2018-2024) & (US$ Million)
Table 49. China Hemoglobinopathy Testing Services Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Hemoglobinopathy Testing Services Market Size by Application (2018-2024) & (US$ Million)
Table 51. China Hemoglobinopathy Testing Services Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Hemoglobinopathy Testing Services Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia Hemoglobinopathy Testing Services Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Hemoglobinopathy Testing Services Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia Hemoglobinopathy Testing Services Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Hemoglobinopathy Testing Services Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Hemoglobinopathy Testing Services Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia Hemoglobinopathy Testing Services Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size by Country (2024-2029) & (US$ Million)
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Hemoglobinopathy Testing Services Product
Table 69. Novartis Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 70. Novartis Recent Developments
Table 71. AstraZeneca Company Details
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Hemoglobinopathy Testing Services Product
Table 74. AstraZeneca Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 75. AstraZeneca Recent Developments
Table 76. Bluebird Bio Company Details
Table 77. Bluebird Bio Business Overview
Table 78. Bluebird Bio Hemoglobinopathy Testing Services Product
Table 79. Bluebird Bio Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 80. Bluebird Bio Recent Developments
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Hemoglobinopathy Testing Services Product
Table 84. Bristol-Myers Squibb Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Developments
Table 86. Emmaus Medical Company Details
Table 87. Emmaus Medical Business Overview
Table 88. Emmaus Medical Hemoglobinopathy Testing Services Product
Table 89. Emmaus Medical Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 90. Emmaus Medical Recent Developments
Table 91. Acceleron Pharma Company Details
Table 92. Acceleron Pharma Business Overview
Table 93. Acceleron Pharma Hemoglobinopathy Testing Services Product
Table 94. Acceleron Pharma Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 95. Acceleron Pharma Recent Developments
Table 96. HemaQuest Pharmaceuticals Company Details
Table 97. HemaQuest Pharmaceuticals Business Overview
Table 98. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Product
Table 99. HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 100. HemaQuest Pharmaceuticals Recent Developments
Table 101. Eli Lilly and Company Company Details
Table 102. Eli Lilly and Company Business Overview
Table 103. Eli Lilly and Company Hemoglobinopathy Testing Services Product
Table 104. Eli Lilly and Company Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 105. Eli Lilly and Company Recent Developments
Table 106. Celgene Corporation Company Details
Table 107. Celgene Corporation Business Overview
Table 108. Celgene Corporation Hemoglobinopathy Testing Services Product
Table 109. Celgene Corporation Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 110. Celgene Corporation Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Hemoglobinopathy Testing Services Market Share by Type: 2022 VS 2029
Figure 3. Hydroxyurea Features
Figure 4. Glutamine Features
Figure 5. Zynteglo Features
Figure 6. Luspatercept Features
Figure 7. Others Features
Figure 8. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Hemoglobinopathy Testing Services Market Share by Application: 2022 VS 2029
Figure 10. Sickle Cell Diseases Case Studies
Figure 11. Thalassemia Case Studies
Figure 12. Other Case Studies
Figure 13. Hemoglobinopathy Testing Services Report Years Considered
Figure 14. Global Hemoglobinopathy Testing Services Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Hemoglobinopathy Testing Services Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Hemoglobinopathy Testing Services Market Share by Region: 2022 VS 2029
Figure 17. Global Hemoglobinopathy Testing Services Market Share by Players in 2022
Figure 18. Global Top Hemoglobinopathy Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Testing Services as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Hemoglobinopathy Testing Services Revenue in 2022
Figure 20. North America Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Hemoglobinopathy Testing Services Market Share by Type (2018-2029)
Figure 22. North America Hemoglobinopathy Testing Services Market Share by Application (2018-2029)
Figure 23. North America Hemoglobinopathy Testing Services Market Share by Country (2018-2029)
Figure 24. United States Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Hemoglobinopathy Testing Services Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Hemoglobinopathy Testing Services Market Share by Type (2018-2029)
Figure 28. Europe Hemoglobinopathy Testing Services Market Share by Application (2018-2029)
Figure 29. Europe Hemoglobinopathy Testing Services Market Share by Country (2018-2029)
Figure 30. Germany Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Hemoglobinopathy Testing Services Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Hemoglobinopathy Testing Services Market Share by Type (2018-2029)
Figure 38. China Hemoglobinopathy Testing Services Market Share by Application (2018-2029)
Figure 39. Asia Hemoglobinopathy Testing Services Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Hemoglobinopathy Testing Services Market Share by Type (2018-2029)
Figure 41. Asia Hemoglobinopathy Testing Services Market Share by Application (2018-2029)
Figure 42. Asia Hemoglobinopathy Testing Services Market Share by Region (2018-2029)
Figure 43. Japan Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Hemoglobinopathy Testing Services Market Share by Country (2018-2029)
Figure 53. Brazil Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Novartis Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 60. AstraZeneca Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 61. Bluebird Bio Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 63. Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 64. Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 65. HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 67. Celgene Corporation Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries